Leor Weinberger, PhD
Research Associate WOS
Pharmaceutical Chemistry
School of Pharmacy

leor.weinberger@ucsf.edu

Weinberger and colleagues discovered the HIV latency circuit (Weinberger* et al. Cell 2005), which provided the first experimental evidence that stochastic fluctuations (‘noise’) in gene expression drive biological fate decisions. Noise-driven decisions were then found in systems ranging from bacteria to cancer.

The lab's studies overturned dogma in the field by showing that HIV latency was a ‘hardwired’ virus program (Razooky et al. Cell 2015; Rouzine et al. Cell 2015) and discovered stochastic latency programs in other viruses (Chaturvedi et al. PNAS 2020). For these contributions, Weinberger received the NIH Avant-Garde award for HIV research and an NIH Merit Award.

The lab discovered noise-enhancer molecules (Dar et al. Science 2014), now used by numerous other labs—e.g., to modulate circadian rhythms (Li et al. PNAS 2020)—and discovered a cellular noise-control pathway that potentiates embryonic cell-fate transitions (Desai et al. Science 2021). These studies demonstrated that transcriptional noise can be a ‘feature not a bug’ of cellular systems and play a functional, physiological role.

On the therapeutic front, the lab conceptualized and forwarded Therapeutic Interfering Particles (TIPs) (Weinberger et al. J Virol. 2003)—a first-in-class antiviral countermeasure that is single-dose and escape-resistant (see TED talk, below). The lab's initial work led to the DARPA INTERCEPT program (a $40M initiative that funded dozens of virology labs worldwide from 2015–20). In 2020, the lab discovered TIPs for SARS-CoV-2 (Chaturvedi et al. Cell 2021)—the first TIP reported for any virus—and provided long-sought evidence for the therapeutic effect of the TIP mechanism of action. Following FDA reviews, the DoD and NIH funded TIP clinical trials for HIV and SARS-CoV-2.

Awards

  • Seattle Children's Research Innovator Award (Inaugural), 2022
  • Oustanding Mentor award, Gladstone/UCSF, 2022
  • NIH Director's Transformative Research Award (TRA), 2021
  • NIH MERIT Award, 2021
  • NIH Avant-Garde Award, 2020
  • William and Ute Bowes Distinguished Professor, 2017
  • Blavatnik Scholar, 2016
  • American Institute for Mechanical and Biological Engineering (AIMBE), College of Fellows, 2015
  • NIH Director's Pioneer Award, 2013
  • NIH/NIDA Avant Garde Award for HIV Research (deferred), 2013
  • Alfred P. Sloan Research Fellow, 2011
  • Bill & Melinda Gates Foundation, Grand Challenges Award, 2009
  • California HIV/AIDS Foundation, Young Investigator Innovative Development Award, 2009
  • NIH Director's New Innovator Award, 2009
  • W.M. Keck Foundation, Research Excellence Award, 2009
  • NIH K25 Career Development Award, 2008
  • Pew Scholar in the Biomedical Sciences, 2008
  • Lewis Thomas Fellowship, Princeton University, 2004
  • E. Cota-Robles Fellowship, UC Berkeley, 1999
  • Howard Hughes Medical Institute (HHMI) Pre-Doctoral Fellowship, 1999
  • HHMI Undergraduate Research Fellowship, 2nd Award, 1997
  • John Prost Award, University of Maryland, 1997
  • Maryland Distinguished Scholar, 1996
  • HHMI Undergraduate Research Fellowship, 1995
  • NIH FAES Fellow, 1993

Education & Training

Show all (3) Hide

  • Lewis-Thomas Fellow Molecular Biology Princeton University 2007
  • Ph.D. Biophysics University of California, Berkeley 2004
  • B.Sc. Biology, Physics University of Maryland, College Park (Hons.) 1998

Interests

Show all (3) Hide

  • synthetic biology
  • virology
  • expression noise

Websites

Show all (3) Hide

Grants and Projects

Publications (72)

Top publication keywords:
HIV Long Terminal RepeatFeedback, Physiologicaltat Gene Products, Human Immunodeficiency VirusStochastic ProcessesHIV-1Gene Expression Regulation, ViralVirus ReplicationRNA, MessengerHIVAntiviral AgentsVirus LatencyDefective VirusesSingle Molecule ImagingCytomegalovirusTranscription, Genetic